Navigation Links
ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA
Date:9/14/2009

the know-how needed to provide constant auditing and control monitoring required for IT security governance, risk, and compliance initiatives.

"To improve the effectiveness of CPM and BI investments, consider the following:

  • Establish a BI and CPM competency center that brings together business and IT personnel to determine reporting issues and how to align technologies to address any concerns.

  • Understand how CPM can benefit the organization, and work in close collaboration to enable CPM platforms that are consistent with the IT portfolio.

  • Define and deploy an enterprisewide metrics framework. Organizations need to have a consistent set of clearly defined performance metrics, aligned to corporate strategy and recognizable by all stakeholders."

ATV: 2009 Gartner FEI Technology Study Research Collection, 31 August 2009 by John E. Van Decker Research VP

The ClearPoint Metric Application Packages are built on ClearPoint's methodology for designing relevant, actionable, and trustworthy security metrics that are aligned to an organization's objectives and reporting structure. The company's exclusive 'Metric Roll Up' capability enables organizations to fuse together data from a wide variety of security and enterprise applications, generate metrics, and then 'slice & dice', group, and sort the metrics into scorecards and dashboards appropriate for the audience or stakeholder. The end result is that users collaborate around visually rich scorecards that provide high level indicators with the ability to drill in to fine grain details and root causes, enabling executives and managers to make decisions with information that is consistent and trustworthy.


'/>"/>
SOURCE ClearPoint Metrics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. United American Healthcare Corporation Announces Release Date for Fiscal 2009 Fourth Quarter and Full Year Results
2. Nuvilex, Inc. Announces Reme-Flu(TM) as Trade Name for All-Natural Flu Remedy Formula
3. JAG Media Holdings, Inc. Announces Agreement with The Investor Relations Group, Inc.
4. DURECT Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million
5. Cardinal Health Announces Early Tender Results of Debt Tender Offer
6. Pro-Dex, Inc. Announces Fiscal 2009 Fourth Quarter Financial Results Conference Call and Webcast
7. Edward Announces New Neurosciences Institute in Partnership With Northwestern Medical Faculty Foundation
8. Regeneron Announces September 2009 Investment Conference Presentations
9. Amedica Announces New Global Headquarters
10. Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces
11. TEDIndia Announces List of Inspiring Speakers from Across the Globe

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)..., The Academy of General ...f Orange county CA, received the Mastership Award ...ognizes AGD members, commitment to excellence in d...ompleted 1,100 hours of approved continuing dental...luding 400 hours dedicated to hands-on skills and ...
(Date:11/29/2009)... Witnessing someone get blamed for something leads...ds , , SUNDAY, Nov. 29 (HealthDay News) ... reports, even when the target is innocent. , R...e someone else for a problem, even if it,s an unfa...in blaming others, too. , "When we see others ...
(Date:11/29/2009)..., Traditional healthcare,...for viable affordable alternative care. Affordable... (PRWEB) November 29, 2009 -- Af...June of this year (2009) and has been met with ent...nd rapid success can be attributed to two things, ...
(Date:11/28/2009)... Study finds gene variation believed to affect cir...(HealthDay News) -- New research suggests that an ...e a factor in the development of bipolar disorder ...amination of the genetic makeup of 152 children wi...ible to major mood swings, and 140 children withou...
(Date:11/27/2009)..., Biotech firm Replikins ...of the H1N1 virus genomic data. It shows that the...of 3.7 (s.d. 4.5) during the virus,s current outbr...levels this week of 2.0 (s.d. 0.1). The H1N1 infec... Boston (PRWEB) November 27, 200...
Breaking Medicine News(10 mins):Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5
...23 As the hundreds of thousands San,Diegans flee ...appened and,deal with the stress of the situation....of stress and anxiety for those directly and indir...ear and anxiety about the future -- Disorientatio...
..., Preliminary and Subspecialty Reports Day or Nigh...pecialty,Radiology (F&S) announces that it has exp...l to now offer final and preliminary night time,in...er of final reports, as well as the largest subspe...
.... 23 Children are the most dependent on,others an...ster strikes,according to a trauma expert. "Why d... two sources of,security for a child: the security...rt R. Butterworth, Ph.D. Dr. Butterworth added, "...
...s Association Offers Tips for People with Diabetes...dfires, ALEXANDRIA, Va., Oct. 23 The American Di... for people with diabetes who,are affected by the ... Medication and Supplies -- ADA recommends having ...
...Oct. 23 Thermo Fisher,Scientific Inc. (NYSE: TMO...ounced it has broken ground on a new $17 million (...ing demand for biopharma services in that,country....ing in clinical trials across the globe. It will,c...
...Oct. 23 Cardiac Science,Corporation (Nasdaq: CSC...g,and defibrillation products, announced today tha... results on Tuesday, October 30, 2007 after the,ma...e third quarter and current business developments....
Other Medicine News:Health News:Coping with the Stress of Natural Disasters 2Health News:Franklin & Seidelmann Enters Full-Service Teleradiology Market with Acquisition of Apex Radiology 2Health News:Franklin & Seidelmann Enters Full-Service Teleradiology Market with Acquisition of Apex Radiology 3Health News:California Wildfires - Psychological Effects; Children ... Psychologist Is Available to Discuss Trauma 2Health News:Emergency Preparedness for People With Diabetes 2Health News:Thermo Fisher Scientific Expands Clinical Trial Services Capabilities with New Facility in India 2Health News:Thermo Fisher Scientific Expands Clinical Trial Services Capabilities with New Facility in India 3Health News:Thermo Fisher Scientific Expands Clinical Trial Services Capabilities with New Facility in India 4Health News:Cardiac Science Corporation Schedules Third Quarter Earnings Release and Announces Conference Call 2
(Date:11/26/2009)..., , JOHANNESBURG, South Africa, Nov. 26...th Africa Company of the Year Award in the Generic...o South Africa Limited. ,, (Logo: http://www.n...r the Company of the Year Award, the following cri...mance against key competitors: growth strategy and...
(Date:11/25/2009)..., , WESTON, Fla., Nov. 25 /PRNewswire...(Pink Sheets: ASFX) ("the Company") is pleased to ...g and production management office in Shanghai, Ch...abroad, providing an essential gateway for the dev...th and safety products for children and adults to ...
(Date:11/25/2009)..., , BEDFORD, Mass., Nov. 25 /PRNewswire-...y) (Nasdaq: HOLX ), a leading developer, manufact...imaging systems and surgical products dedicated to...he annual meeting of the Radiological Society of N... November 29 through December 3, 2009 to highlight...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4YORK Label Announces Continued Investment in the Company 55202 1YORK Label Announces Continued Investment in the Company 55202 2RN Super Union Adopts Name 3A National Nurses United Sets Founding Convention Dec 7 in Arizona 55199 1RN Super Union Adopts Name 3A National Nurses United Sets Founding Convention Dec 7 in Arizona 55199 2New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 1New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 2
...RE)--Apr 14, 2007 - In a late-breaker,presentation...ation,for the Study of the Liver (EASL), researche...lysis of the PROVE 1 clinical trial,which is the ...h,the investigational hepatitis C protease inhibit...gylated interferon (peg-IFN) and,ribavirin (RBV) i...
...Apr 16, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ZI...lin (ZIO-301) at the American Association of Cance...ta demonstrate that,indibulin has distinct biologi...ing agents and strongly suggest a very different,t...heral,neuropathy. While indibulin binds to tubulin...
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR 2ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR 3
Optima III 45 Noninsulated Duck-Bill Grasper, with ratchet
Optima III Noninsulated Babcock Grasper, with ratchet
Optima III Noninsulated Stabilizing Grasper, with ratchet
Optima III Noninsulated Retraction Grasper, with ratchet
Medicine Products: